Nanofacile Wins the DEVTECH 2024 Entrepreneurial Competition !
Nanofacile is proud to have been selected as one of the winning startups in the prestigious DEVTECH 2024 entrepreneurial competition, organized by Québec International and Québec VITAE. This provided us with a valuable opportunity to showcase our innovative approach to accelerating the development of targeted RNA therapies.
This recognition reinforces our mission to transform the future of medical treatments by harnessing the potential of RNA to combat various pathologies. With the support of Quebec International and V1 Studio, we will take part in two major conferences : Redefining Early Stage Investments 2025 and BIO International Convention 2025. These key events will provide valuable opportunities to connect with industry leaders while playing a crucial role in accelerating our development.
A huge thank you to Québec International, Québec VITAE, and all our partners for their support, as well as to our dynamic team and collaborators, without whom this victory would not have been possible.
Congratulations also to our colleagues 9Bio and EncephalIX, as well as to all the startups that presented inspiring and innovative projects. This competition testifies to the vitality and exceptional potential of the life sciences ecosystem in Quebec.
The adventure is just beginning, and we look forward to sharing with you the exciting next steps in our journey!
Related Posts
